Lataa...
Paroxysmal cold hemoglobinuria successfully treated with complement inhibition
This is the first-ever demonstration of successful treatment of paroxysmal cold hemoglobinuria using the complement inhibitor eculizumab.
Tallennettuna:
| Julkaisussa: | Blood Adv |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society of Hematology
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6880888/ https://ncbi.nlm.nih.gov/pubmed/31738828 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000897 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|